Top Markets
Coin of the day
Cordlife Group Limited Cordlife Group Limited

Cordlife Group Limited

P8A
株式のランク #28424
Established in Singapore in 2001, Cordlife Group Limited functions as an... Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.
株価
$0.10366179
時価総額
$26.57M
変化(1日)
-9.66%
変化(1年)
-33.40%
SG
取引 Cordlife Group Limited (P8A)

カテゴリー

Cordlife Group Limited(P8A)の配当利回りの履歴
Cordlife Group Limited(銘柄コード: P8A)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Cordlife Group Limited(P8A)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)